Pharmaceutical Industry News

News in the Pharmaceutical Industry. The Latest News form Origin Pharma Packaging, a Leading Global Manufacturer.

The Drug Development Process

When a new drug hits the development stage it can go through a lengthy and complex process before it is seen by the public or distributed to pharmacies. In reality, only two tested innovations out of 10,000 actually become fully licensed treatments. All in all, it can take an average of ten to fifteen years…

WHO is W.H.O.?

Sunday, April 7th is World Health Day, an annual campaign built to increase global awareness of universal health coverage with a particular focus on what services should be available. The event Is organized by the World Health Organization, and signals a major date in their calendar. But exactly who is WHO, and what are their…

Blue Ocean Strategy:

It’s very easy to go about your day to day life without thinking about the impact the products you buy and use have on the environment. Although there has been a surge in interest in single-use plastics, the reality is that many of us aren’t aware of the damage we’re doing to the planet. Every…

Keeping up with biologics:

GSK, Bristol-Myers Squibb, Novartis and AstraZeneca to name but a few are investing billions of dollars in biologics to have prime mover advantage in a market forecast to be worth nearly $480 billion by 2024. It’s clear biologics are the future of medicine based on their proven ability to treat major chronic diseases better than…

A plastic revolution: How packaging innovation is helping the fight against plastic waste

Meeting in Nairobi in December 2017, the United Nations Environment Assembly committed to a new resolution, urging all countries, ‘to prevent and significantly reduce marine pollution of all kinds, in particular from land-based activities’ by 2025. It claims, unless we take action, our oceans will contain more plastic than fish by 2050. The call to…

Pack to the future

Pharmaceuticals companies are experiencing a wave of competing challenges as part of what PwC refers to as the New Health Economy. These include market consolidation for efficiency gains; the changing demands and needs of patients and increasing cost pressures from payors leading to calls for pricing reform. Jon Lant, Head of New Product Development & Innovation,…